357 related articles for article (PubMed ID: 33791889)
1. Expanding spectrum of DADA2: a review of phenotypes, genetics, pathogenesis and treatment.
Pinto B; Deo P; Sharma S; Syal A; Sharma A
Clin Rheumatol; 2021 Oct; 40(10):3883-3896. PubMed ID: 33791889
[TBL] [Abstract][Full Text] [Related]
2. Deficiency of Adenosine Deaminase 2 (DADA2): Updates on the Phenotype, Genetics, Pathogenesis, and Treatment.
Meyts I; Aksentijevich I
J Clin Immunol; 2018 Jul; 38(5):569-578. PubMed ID: 29951947
[TBL] [Abstract][Full Text] [Related]
3. Deficiency of Adenosine Deaminase 2: Clinical Manifestations, Diagnosis, and Treatment.
Grim A; Veiga KR; Saad N
Rheum Dis Clin North Am; 2023 Nov; 49(4):773-787. PubMed ID: 37821195
[TBL] [Abstract][Full Text] [Related]
4. Monogenic polyarteritis: the lesson of ADA2 deficiency.
Caorsi R; Penco F; Schena F; Gattorno M
Pediatr Rheumatol Online J; 2016 Sep; 14(1):51. PubMed ID: 27609179
[TBL] [Abstract][Full Text] [Related]
5. Deficiency of adenosine deaminase 2 (DADA2): Review.
Sharma V; Deo P; Sharma A
Best Pract Res Clin Rheumatol; 2023 Mar; 37(1):101844. PubMed ID: 37328410
[TBL] [Abstract][Full Text] [Related]
6. Deficiency of Adenosine Deaminase 2 (DADA2), an Inherited Cause of Polyarteritis Nodosa and a Mimic of Other Systemic Rheumatologic Disorders.
Hashem H; Kelly SJ; Ganson NJ; Hershfield MS
Curr Rheumatol Rep; 2017 Oct; 19(11):70. PubMed ID: 28983775
[TBL] [Abstract][Full Text] [Related]
7. Deficiency of Human Adenosine Deaminase Type 2 - A Diagnostic Conundrum for the Hematologist.
Pilania RK; Banday AZ; Sharma S; Kumrah R; Joshi V; Loganathan S; Dhaliwal M; Jindal AK; Vignesh P; Suri D; Rawat A; Singh S
Front Immunol; 2022; 13():869570. PubMed ID: 35592317
[TBL] [Abstract][Full Text] [Related]
8. Diagnosis and management of ADA2 deficient polyarteritis nodosa.
Human A; Pagnoux C
Int J Rheum Dis; 2019 Jan; 22 Suppl 1():69-77. PubMed ID: 29624883
[TBL] [Abstract][Full Text] [Related]
9. A Monogenic Disease with a Variety of Phenotypes: Deficiency of Adenosine Deaminase 2.
Özen S; Batu ED; Taşkıran EZ; Özkara HA; Ünal Ş; Güleray N; Erden A; Karadağ Ö; Gümrük F; Çetin M; Sönmez HE; Bilginer Y; Ayvaz DÇ; Tezcan I
J Rheumatol; 2020 Jan; 47(1):117-125. PubMed ID: 31043544
[TBL] [Abstract][Full Text] [Related]
10. Hematopoietic stem cell transplantation rescues the hematological, immunological, and vascular phenotype in DADA2.
Hashem H; Kumar AR; Müller I; Babor F; Bredius R; Dalal J; Hsu AP; Holland SM; Hickstein DD; Jolles S; Krance R; Sasa G; Taskinen M; Koskenvuo M; Saarela J; van Montfrans J; Wilson K; Bosch B; Moens L; Hershfield M; Meyts I;
Blood; 2017 Dec; 130(24):2682-2688. PubMed ID: 28974505
[TBL] [Abstract][Full Text] [Related]
11. A case series of ten plus one deficiency of adenosine deaminase 2 (DADA2) patients in Iran.
Asna Ashari K; Aslani N; Parvaneh N; Assari R; Heidari M; Fathi M; Tahghighi Sharabian F; Ronagh A; Shahrooei M; Moafi A; Rezaei N; Ziaee V
Pediatr Rheumatol Online J; 2023 Jun; 21(1):55. PubMed ID: 37312195
[TBL] [Abstract][Full Text] [Related]
12. Vasculopathy, Immunodeficiency, and Bone Marrow Failure: The Intriguing Syndrome Caused by Deficiency of Adenosine Deaminase 2.
Lee PY
Front Pediatr; 2018; 6():282. PubMed ID: 30406060
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous vasculitis in autoinflammatory diseases.
Chen KR
J Dermatol; 2024 Feb; 51(2):150-159. PubMed ID: 37955334
[TBL] [Abstract][Full Text] [Related]
14. The Many Faces of a Monogenic Autoinflammatory Disease: Adenosine Deaminase 2 Deficiency.
Kendall JL; Springer JM
Curr Rheumatol Rep; 2020 Aug; 22(10):64. PubMed ID: 32845415
[TBL] [Abstract][Full Text] [Related]
15. Mechanisms of vascular inflammation in deficiency of adenosine deaminase 2 (DADA2).
Lee PY; Aksentijevich I; Zhou Q
Semin Immunopathol; 2022 May; 44(3):269-280. PubMed ID: 35178658
[TBL] [Abstract][Full Text] [Related]
16. ADA2 deficiency (DADA2) as an unrecognised cause of early onset polyarteritis nodosa and stroke: a multicentre national study.
Caorsi R; Penco F; Grossi A; Insalaco A; Omenetti A; Alessio M; Conti G; Marchetti F; Picco P; Tommasini A; Martino S; Malattia C; Gallizzi R; Podda RA; Salis A; Falcini F; Schena F; Garbarino F; Morreale A; Pardeo M; Ventrici C; Passarelli C; Zhou Q; Severino M; Gandolfo C; Damonte G; Martini A; Ravelli A; Aksentijevich I; Ceccherini I; Gattorno M
Ann Rheum Dis; 2017 Oct; 76(10):1648-1656. PubMed ID: 28522451
[TBL] [Abstract][Full Text] [Related]
17. A 9.5-year-old boy with recurrent neurological manifestations and severe hypertension, treated initially for polyarteritis nodosa, was subsequently diagnosed with adenosine deaminase type 2 deficiency (DADA2) which responded to anti-TNF-α.
Sahin S; Adrovic A; Barut K; Baran S; Tahir Turanli E; Canpolat N; Kizilkilic O; Ozkaya O; Kasapcopur O
Paediatr Int Child Health; 2020 Feb; 40(1):65-68. PubMed ID: 30642227
[TBL] [Abstract][Full Text] [Related]
18. Identification of Novel Adenosine Deaminase 2 Gene Variants and Varied Clinical Phenotype in Pediatric Vasculitis.
Gibson KM; Morishita KA; Dancey P; Moorehead P; Drögemöller B; Han X; Graham J; Hancock REW; Foell D; Benseler S; Luqmani R; Yeung RSM; Shenoi S; Bohm M; Rosenberg AM; Ross CJ; Cabral DA; Brown KL;
Arthritis Rheumatol; 2019 Oct; 71(10):1747-1755. PubMed ID: 31008556
[TBL] [Abstract][Full Text] [Related]
19. Genotype and functional correlates of disease phenotype in deficiency of adenosine deaminase 2 (DADA2).
Lee PY; Kellner ES; Huang Y; Furutani E; Huang Z; Bainter W; Alosaimi MF; Stafstrom K; Platt CD; Stauber T; Raz S; Tirosh I; Weiss A; Jordan MB; Krupski C; Eleftheriou D; Brogan P; Sobh A; Baz Z; Lefranc G; Irani C; Kilic SS; El-Owaidy R; Lokeshwar MR; Pimpale P; Khubchandani R; Chambers EP; Chou J; Geha RS; Nigrovic PA; Zhou Q
J Allergy Clin Immunol; 2020 Jun; 145(6):1664-1672.e10. PubMed ID: 31945408
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]